Merkel Cell Carcinoma with Spontaneous Regression: A Case Report and Immunohistochemical Study

Case Reports in Dermatology

Volumn 8, Issue 1, 2016, Pages 52-58

  Terui, Hitoshi ^a,b   Fujimura, Taku ^a   Kakizaki, Aya ^a   Furudate, Sadanori ^a   Aiba, Setsuya ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SENDAI CITY HOSPITAL   (Japan)

Author keywords

Granulysin; Merkel cell carcinoma; Spontaneous regression; Tumor associated macrophages

Indexed keywords

ANTIGEN; CASPASE 3; CD163 ANTIGEN; CD206 ANTIGEN; CD8 ANTIGEN; CYTOKERATIN 20; GRANULYSIN; MELAN A; MONOCLONAL ANTIBODY HMB 45; NEURON SPECIFIC ENOLASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER REGRESSION; CASE REPORT; CHEEK; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MERKEL CELL TUMOR; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN BIOPSY; TUMOR ASSOCIATED LEUKOCYTE; VERY ELDERLY;

EID: 84988710302     PISSN: None     EISSN: 16626567     Source Type: Journal    
DOI: 10.1159/000444317     Document Type: Article

References (17)

1. Ferringer T, Rogers HC, Metcalf JS: Merkel cell carcinoma in situ. J Cutan Pathol 2005;32:162-165.
2. Van Keymeulen A, Mascre G, Youseff KK, Harel I, Michaux C, De Geest N, Szpalski C, Achouri Y, Bloch W, Hassan BA, Blanpain C: Epidermal progenitors give rise to Merkel cells during embryonic development and adult homeostasis. J Cell Biol 2009;187:91-100.
3. Fujimoto N, Nakanishi G, Kabuto M, Nakano T, Eto H, Nakajima H, Sano S, Tanaka T: Merkel cell carcinoma showing regression after biopsy: evaluation of programmed cell death 1-positive cells. J Dermatol 2015;42:496-499.
4. Kayashima K, Ono T, Johno M, Kojo Y, Yamashita N, Matsunaga W: Spontaneous regression in Merkel cell (neuroendocrine) carcinoma of the skin. Arch Dermatol 1991;127:550-553.
5. Duncan WC, Tschen JA: Spontaneous regression of Merkel cell (neuroendocrine) carcinoma of the skin. J Am Acad Dermatol 1993;29:653-654.
6. Paulson KG, Iyer JG, Tegeder AR, et al: Transcriptome-wide studies of Merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J Clin Oncol 2011;29:1539-1546.
7. Dowlatshahi M, Huang V, Gehad AE, et al: Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses. J Invest Dermatol 2013;133:1879-1889.
8. Asgari MM, Sokil MM, Warton EM, et al: Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma. JAMA Dermatol 2014;150:716-723.
9. Krensky AM, Clayberger C: Granulysin: a novel host defense molecule. Am J Transplant 2005;5:1789-1792.
10. Pagès F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Galon J: Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005;353:2654-2666.
11. Kambayashi Y, Fujimura T, Furudate S, Hashimoto A, Haga T, Aiba S: Comparison of immunosuppressive cells and cytotoxic cells in angiosarcoma: the development of a possible supportive therapy for angiosarcoma. Dermatology 2013;227:14-20.
12. Furudate S, Fujimura T, Kambayashi Y, Kawano M, Ogasawara K, Tsukada A, Tamabuchi E, Haga T, Hashimoto A, Aiba S: Successful treatment of adult onset Langerhans cell histiocytosis with bi-weekly administration of pegylated interferon-α. Acta Derm Venereol 2014;94:611-612.
13. Furudate S, Fujimura T, Tsukada A, Numata Y, Kambayashi Y, Aiba S: Profiles of tumor-infiltrating lymphocytes in a case of trichilemmal carcinoma with spontaneous regression. Case Rep Dermatol 2012;4:215-221.
14. Kambayashi Y, Fujimura T, Furudate S, Asano M, Kakizaki A, Aiba S: The possible interaction between receptor activator of nuclear factor kappa-B ligand (RANKL) expressed by extramammary Paget cells and its ligand on dermal macrophages. J Invest Dermatol 2015;135:2547-2550.
15. Kakizaki A, Fujimura T, Kambayashi Y, Furudate S, Kawano M, Ogasawara K, Aiba S: Comparison of CD163+ macrophages and CD206+ cells in lesional skin of CD30+ lymphoproliferative disorders of lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Acta Derm Venereol 2015;95:600-602.
16. Fujimura T, Kambayashi Y, Furudate S, Asano M, Kakizaki A, Aiba S: Receptor activator of nuclear factor kappa-B ligand (RANKL) promotes the production of CCL17 from RANK+ M2 macrophages. J Invest Dermatol 2015;135:2884-2887.
17. Fujimura T, Kambayashi Y, Furudate S, Kakizaki A, Aiba S: Immunomodulatory effect of bisphosphonate risedronate sodium on CD163+ arginase1+ M2 macrophages: the development of a possible supportive therapy for angiosarcoma. Clin Dev Immunol 2013;2013:325412.